Inotuzumab (Anti-Siglec-2 / CD22)
Product Specifications
CAS Number
1660159-36-3
Synonyms
Humanized Anti-CD22 Recombinant Antibody
SKU
C00172-1mg
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Inotuzumab (Anti-Siglec-2 / CD22) is a humanized IgG4, κ monoclonal antibody that targets CD22. Inotuzumab can be used for the research of acute lymphoblastic leukaemia and non-Hodgkin lymphoma. MW : 144.78 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog